Abstract
ObjectiveTo compare the effectiveness, safety and costs of standard versus individually tailored reduced doses of anti-tumour necrosis factor (TNF) drugs in patients with ankylosing spondylitis (AS) after achieving low-disease activity.MethodsThis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have